GuidelineHuman reproduction (Oxford, England)2021
The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic.
Guideline in Human reproduction (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of SARS-CoV-2 infection on clinical outcomes ofFrontiers in endocrinology · 2023Pooled it
- Sociodemographic and medical correlates of fertility-related quality of life in primary infertile Czech couples attending fertility clinics.Health psychology report · 2026Article
- The Prediction of IVF Outcomes with Autologous Oocytes and the Optimal MII Oocyte/Embryo Number for Live Birth at Advanced Maternal Age.Medicina (Kaunas, Lithuania) · 2023Article
- Survey on the Impact of COVID-19 on the Practice of Assisted Reproduction in Latin America.JBRA assisted reproduction · 2023Article
- Association between tissue stress reaction and ACE2/TMPRSS2 expression in endometria of reproductive aged women before and during Covid-19 pandemic.BMC women's health · 2023Article
- SARS-CoV-2, fertility and assisted reproduction.Human reproduction update · 2023Review
- COVID-19-related uncertainty: fertility staff experiences of its sources, processing, responses, and consequences.Human reproduction (Oxford, England) · 2023Article
- Semen parameters after SARS-CoV-2 infection: A literature review.Health science reports · 2022Article
- Medically assisted procreation in times of COVID-19: what impact on health care system organization and the reproductive rights of couples?Acta bio-medica : Atenei Parmensis · 2021Article
- Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction.Human reproduction (Oxford, England) · 2021Article
- Effects of the early phase of the COVID-19 pandemic on natural and ART-mediated birth rates in Lombardy Region, Northern Italy.Reproductive biomedicine online · 2021Article
- Controlled Ovarian Hyperstimulation Protocol in Infertile Patients During the COVID-19 Pandemic.Frontiers in physiology · 2021Article
- Impact of COVID-19 Pandemic on Clinical and Embryological Outcomes of Assisted Reproductive Techniques.Journal of human reproductive sciencesArticle
- A multi-faceted exploration of unmet needs in the continuing improvement and development of fertility care amidst a pandemic.International braz j urol : official journal of the Brazilian Society of UrologyArticle
- Resuming Assisted Reproduction Services during COVID-19 Pandemic: An Initial Indian Experience.Journal of human reproductive sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.